Internalization of growth factor-receptor complexes under the influence of antibodies initiates cell apoptosis in vitro

Ashman, 1994, Bpitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, JB5.B8, 17F11, and SR-1, J. Cell. Physiol, 158, 545, 10.1002/jcp.1041580321 Bellamy, 1997, p 53 and apoptosis, Br. Med. Bull, 53, 538, 10.1093/oxfordjournals.bmb.a011628 Blagoveshenskaia, 1994, The dependence of the endocytosis of the epidermal growth factor receptors on the degree of receptor occupancy, Tsitologiia (Russia), 36, 664 Duronio, 1991, Antibodies to interleukin 3 as probes for the interaction of interleukin 3 with its receptor, Cytokine, 3, 414, 10.1016/1043-4666(91)90045-F Fotedar, 1996, Apoptosis and the cell cycle, Prog. Cell Cycle Res, 2, 147, 10.1007/978-1-4615-5873-6_15 Haimovitz-Friedman, 1997, Ceramide signalling in apoptosis, Br. Med. Bull, 53, 539, 10.1093/oxfordjournals.bmb.a011629 Hunter, 1997, Oncoprotein networks, Cell, 88, 333, 10.1016/S0092-8674(00)81872-3 Ith, 1991, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell, 66, 233, 10.1016/0092-8674(91)90614-5 Jacobson, 1997, Programmed cell death in animal development, Cell, 88, 347, 10.1016/S0092-8674(00)81873-5 Karsan, 1997, Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms, Am. J. Pathol, 151, 1775 Lavrovsky, 1992, High frequency of tumor cell reversion to nontumorigenic phenotype, Eur. J. Cancer, 28, 17, 10.1016/0959-8049(92)90375-C Lavrovsky, 1998, Spontaneous transient reversion of tumor cells, Source of dormant metastasis?. Cancer J, 11, 31 Lyons, 1997, Apoptosis and carcinogenesis, Br. Med. Bull, 53, 554, 10.1093/oxfordjournals.bmb.a011630 Murai, 1996, Apoptosis of human glioma cells in vitro and in vivo induced by neutralizing antibody against human basic fibroblast growth factor, J. Neurosurg, 85, 1072, 10.3171/jns.1996.85.6.1072 Prisco, 1997, The insulin-like growth factor 1 receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal, Mol. Cell. Biol, 17, 1084, 10.1128/MCB.17.3.1084 Sasaki, 1998, Human tumor growth suppression by apoptosis induced with anti-ErbB-2 chimeric monoclonal antibody, Jpn. J. Cancer Res, 89, 562, 10.1111/j.1349-7006.1998.tb03298.x Seki, 1997, Induction of apoptosis in a human hepatocellular carcinoma cell line by neutralizing antibody to transforming growth factor-alpha, Virchows Arch, 430, 29, 10.1007/BF01008013 Shawver, 1994, Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells, Cancer Res, 54, 1367 Vaux, 1997, CED-4 — the third horseman of apoptosis, Cell, 90, 389, 10.1016/S0092-8674(00)80497-3 Wu, 1995, Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin, J. Clin. Invest, 95, 1897, 10.1172/JCI117871 Wyllie, 1997, Apoptosis and carcinogenesis, Eur. J. Cell Biol, 73, 189